ProLease

ProLease

Drug delivery A technology that places injectable formulations in a sustained-release format. See Sustained release.
References in periodicals archive ?
He also coordinates Colliers ABR's MRI property management and financial reporting system, ProLease Lease Management system and other technology advances in the property management group.
The company has several areas of focus: (i) controlled, sustained release of injectable drugs lasting several days to several weeks, utilizing its ProLease and Medisorb(R) technologies and (ii) the development of pharmaceutical products based on proprietary pulmonary drug delivery technologies utilizing its AIR technology.
Nutropin Depot is a long-acting form of Genentech's recombinant human growth hormone using Alkermes' ProLease technology.
based in Cambridge, MA, is developing a widely applicable portfolio of technologies for the delivery of large and small molecule drugs including ProLease (large molecule depot formulations), Medisorb (small molecule depot formation), and AIR (pulmonary delivery technology).